Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 2
2018 1
2021 2
2023 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Smith KL, Ferreiro T, Ribi K, Ruddy K, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O; International Breast Cancer Study Group; POSITIVE Trial Collaborators. Partridge AH, et al. N Engl J Med. 2023 May 4;388(18):1645-1656. doi: 10.1056/NEJMoa2212856. N Engl J Med. 2023. PMID: 37133584 Free PMC article. Clinical Trial.
Interference with the cytolytic activity of interleukin-2-treated lymphocytes by bovine uterine luminal protein.
Segerson EC, Gunsett FC. Segerson EC, et al. Biol Reprod. 1993 May;48(5):1036-41. doi: 10.1095/biolreprod48.5.1036. Biol Reprod. 1993. PMID: 8481467
Bovine uterine luminal protein (ULP) components (> or = 4 x 10(6) and 21,000 M(r)) were obtained from uterine flushings on Day 17 of pregnancy. Experiments were conducted to determine the capability of these components to interfere with the cytolytic activity of …
Bovine uterine luminal protein (ULP) components (> or = 4 x 10(6) and 21,000 M(r)) were obtained from uterine flushings on …
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.
Nelson AJ, Pagidipati NJ, Aroda VR, Cavender MA, Green JB, Lopes RD, Al-Khalidi H, Gaynor T, Kaltenbach LA, Kirk JK, Lingvay I, Magwire ML, O'Brien EC, Pak J, Pop-Busui R, Richardson CR, Reed M, Senyucel C, Webb L, McGuire DK, Granger CB. Nelson AJ, et al. Circulation. 2021 Jul 6;144(1):74-84. doi: 10.1161/CIRCULATIONAHA.121.053766. Epub 2021 Jul 6. Circulation. 2021. PMID: 34228476 Review.
Swept-Source Optical Coherence Tomography Angiography Vascular Metrics as Biomarkers for Renal Function in Patients with Diabetes Mellitus.
Garg I, Duich M, Uwakwe C, Wai KM, Rodriguez JM, Lu ES, Cui Y, Le R, Katz R, Lains I, Vingopoulos F, Moon JY, Zhu Y, Eliott D, Miller JW, Kim LA, Patel NA, Husain D, Vavvas DG, Miller JB. Garg I, et al. Am J Ophthalmol. 2026 Jul;287:151-162. doi: 10.1016/j.ajo.2026.03.017. Epub 2026 Mar 18. Am J Ophthalmol. 2026. PMID: 41856226
Characterization of the M(r) 65,000 lymphokine-activated killer proteins phosphorylated after tumor target binding: evidence that pp65a and pp65b are phosphorylated forms of L-plastin.
Frederick MJ, Rodriguez LV, Johnston DA, Darnay BG, Grimm EA. Frederick MJ, et al. Cancer Res. 1996 Jan 1;56(1):138-44. Cancer Res. 1996. PMID: 8548753
Contact between lymphokine-activated killer (LAK) cells and natural killer-resistant tumor targets SK-Mel-1 (human melanoma) or Raji (human lymphoma) stimulates phosphorylation of two M(r) 65,000 LAK proteins (pp65a and pp65b) with nearly identical iso …
Contact between lymphokine-activated killer (LAK) cells and natural killer-resistant tumor targets SK-Mel-1 (human melanoma) or Raji …
Tumor target binding induces phosphorylation of two M(r) 65,000 lymphokine-activated killer proteins.
Frederick MJ, Rodriguez LV, Johnston DA, Grimm EA. Frederick MJ, et al. Cancer Res. 1996 Jan 1;56(1):127-37. Cancer Res. 1996. PMID: 8548752
Effector-target cell conjugate formation is an essential step during lymphokine-activated killer (LAK) cell-mediated cytotoxicity. Protein phosphorylation changes in human LAKs after contact with NK-resistant (LAK-sensitive) tumors were examined by two-dimensional S …
Effector-target cell conjugate formation is an essential step during lymphokine-activated killer (LAK) cell-mediated cytotoxicity. Pr …